Abstract : It is not fully known if there are signi cant differences in the incidence of post-operative nausea and vomiting PONV in patients undergoing laparoscopic surgery under general anesthesia following administration of des urane compared to other conventional maintenance anesthetics, such as sevoflurane and propofol. This study was aimed to address this issue using network meta-analysis of relevant randomized controlled trials. Summary effect sizes were calculated as odds ratios ORs with 95 con dence intervals CIs . The incidence of PONV after administration of different anesthetics was compared by surface under the cumulative ranking curve SUCRA analysis. The odds of des urane vs sevo urane, des urane vs propofol, and sevo urane vs propofol contributing to the incidence of PONV were 0.44 95 CI, 0.12-1.61 , 2.43 95 CI, 0.72-8.26 , and 5.50 95 CI, 1.78-16.93 , respectively. The SUCRA scores for des urane, sevo urane, and propofol were 48.3, 5.6, and 96.1, respectively. The incidence of PONV after desflurane administration did not differ signi cantly from that after sevo urane and propofol administration. However, the odds of PONV occurring after sevo urane administration were signi cantly higher than those after propofol administration. Moreover, the SUCRA score after desflurane administration was greater than that after sevo urane administration. These results con rm the safety of des urane regarding PONV in patients undergoing laparoscopic surgery under general anesthesia.
recovery, and other issues [1] [2] [3] . Recently, the maintenance anesthetic des urane 2-di uoromethoxy -1, 1, 1, 2-tetra uoroethane became available in Western countries and Japan, and is now widely used in part because patient recovery is relatively rapid 4 . Due to its strong resistance to biodegradation and relatively low metabolism rate 5 , des urane should be able to minimize the incidence of PONV. Previous meta-analyses failed to demonstrate a signi cant difference in the incidence of PONV between patients anesthetized with des urane and those anesthetized with sevo urane 6 . It is also highly controversial whether des urane or other conventional maintenance anesthetics such as sevo urane contribute to signi cant differences in the incidence of PONV in patients undergoing laparoscopic surgery 7 8 . Few studies have evaluated the difference in the incidence of PONV following the administration of des urane and total intravenous anesthesia TIVA using propofol 7 9 .
The lack of consistent information in the literature indicates an unmet medical need for accurate data on the effects of maintenance anesthetics on the incidence of PONV. This study used network meta-analysis of randomized controlled trials RCTs to compare the incidence of PONV after administration of des urane and other conventional maintenance anesthetics, such as sevo urane and propofol, in patients undergoing laparoscopic surgery under general anesthesia.
Methods

Publication retrieval and inclusion criteria
The MEDLINE PubMed , Scopus, and Cochrane library databases were searched for publications up to December 2016 using the following queries : postoperative nausea Title / Abstract AND des urane Title OR sevo urane Title OR propofol Title OR TIVA Title AND laparoscopy Title OR laparoscopic Title . The PubMed database was the preferred option for retrieving publications as it has an open access database and is suitable for comprehensive literature searches. The Scopus database was searched to ensure that all eligible articles had been detected in PubMed. The Cochrane library database was also searched to identify additional references. Studies were considered eligible if they met the following criteria : 1 the study was an RCT that assessed the clinical ef cacy or safety of des urane, sevo urane, or propofol, and 2 data on the incidence of PONV were an outcome measure. No restrictions were placed on the search language. The electronic databases were independently searched by 2 investigators KA and AA . When discrepancies occurred between the 2 investigators, a third investigator SI conducted an additional evaluation or our research team resolved the discrepancy through discussion.
Data retrieval and quality assessment
Case reports and single-arm studies were excluded. Studies involving children under 18 years of age were also excluded because the present analysis focused on adult patients only. The Jadad scale was used to evaluate the methodological quality of the included trials based on randomization, blinding, and dropout 10 .
Assessment of risk of bias
Each included study was examined for random sequence generation, allocation concealment, participant and personnel blinding, blinding of outcome assessments, incomplete outcome data, selective reporting, and other forms of potential bias according to the Cochrane methodology 11 .
Data analysis
Network meta-analysis was performed to compare the incidence of PONV following the administration of des urane and other conventional anesthetics, including sevo urane and propofol, using previously described statistical methods 12 13 . Summary effect sizes were determined as odds ratios OR with 95 con dence intervals CIs . Data analysis was performed using Revman 5.3 for Windows Cochrane Corp., Oxford, UK and STATA version 14.0 Stata Corp., College Station, TX .
Ranking investigation
The surface under the cumulative ranking curve SUCRA , de ned as the ratio of the area under the cumulative ranking curve to the entire area of the plot, was calculated to compare each treatment to an ideal treatment that was consistently found to be the best without any uncertainty. In the present analysis, greater SUCRA scores indicated that the treatment was more effective 12 13 .
Evaluation of inconsistency
Network meta-analysis is performed based on the assumption of consistency, which should be con rmed in a closed loop of evidence. Here, the ifferences between direct and indirect evidence, expressed as inconsistency factors with 95 CIs and P values, were calculated by analyzing the equivalence of the 2 types of evidence. Loops in which the lower CI limit did not reach the zero line were considered to exhibit signi cant inconsistency 12 13 .
Results
Search results and characteristics of the included studies
The study selection process is presented in Fig. 1 . Of 39 studies retrieved from the databases, 35 were excluded as they did not compare the incidence of PONV after administration of maintenance anesthetics. The remaining 4 RCTs n 521 subjects met the inclusion criteria and were included in the network meta-analysis presented here 7-9 15 . The characteristics of the 4 RCTs are shown in Table 1 , and the anesthetics employed in these trials are described in Table 2 . The mean age of patients in the 4 RCTs was 37.5-56.1 years. Two of the studies had Jadad scores of 4 and 2 had scores of 3, indicating that these were high quality studies. Fig. 2 presents all comparisons performed in the network meta-analysis. Des urane was comparatively evaluated with sevoflurane and propofol in 2 and 3 RCTs, respectively, and sevoflurane was compared with propofol in 3 RCTs.
Risks of bias
Apart from detection bias in 1 RCT and performance bias in 2 RCTs, all 4 RCTs were found to exhibit a low risk of bias for all evaluated factors. The risk of bias assessments, as determined by the authors, is presented in Fig. 3 .
Mixed comparison for incidence of PONV
The results of the present network meta-analysis are shown in Table 3 . The odds of des urane vs sevo urane, des urane vs propofol, and sevo urane vs propofol in uencing the incidence of PONV were 0.44 95 CI, 0. • Anesthesia : maintained by propofol infusion 6 mg/kg/h , 50 N2O / O2 ventilation.
• Anesthesia : maintained with desflurane average MAC 1.3 , 50 N2O / O2 ventilation.
• Anesthesia : maintained with sevoflurane average MAC 1.3 , 50 N2O / O2 ventilation.
Yoo et al, 2012
• Anesthesia : maintained by propofol 2-5 mcg/ml and remifentanil 2-5 ng/ml infusion.
• Anesthesia : maintained by desflurane end-tidal concentration : 4 -7 and remifentanil effect site concentration : 2-5 ng/ml infusion.
Kawano et al, 2016
• Anesthesia : maintained with sevo urane end-tidal concentration : approximately 1 MAC .
• Anesthesia : maintained by propofol infusion 4-8 mg/kg/h .
Prathep et al, 2015
• Anesthesia : maintained by desflurane infusion end-tidal concentration : 2 -6 .
• Anesthesia : maintained by sevoflurane infusion end-tidal concentration : 0.5 -3 .
• Anesthesia : maintained by propofol infusion effect site concentration : 2-5 mcg/ml .
MAC, minimum alveolar concentration
Analysis of ranking probability
The ranking of each anesthetic is presented in Table 4 . The probabilities of des urane, sevourane, and propofol being the best treatment were 7.6 , 0.1 , and 92.3 , respectively. The corresponding probabilities for being the second-best treatment were 81.4 , 11.0 , and 0.1 , Results are expressed as odds ratio OR with a 95 con dence interval CI for the incidence of PONV with the rst treatment relative to that with the second treatment.
respectively. Similarly, the probabilities for being the third-best treatment were 11.0 , 88.9 , and 0.1 , respectively. The incidence of PONV following administration of des urane, sevo urane, and propofol showed SUCRA scores of 48.3, 5.6, and 96.1, respectively Fig. 4 ; Table 4 .
Inconsistency test
The lower CI limit of IF reached the zero line, and we considered that there was no signicant inconsistency Fig. 5 .
Discussion
In the present network meta-analysis, we assessed the differences in the incidence of PONV a. Probability expressed as a percentage of being the best, second-best, or thirdbest treatment.
b. SUCRA values for the incidence of PONV calculated from the network metaanalysis. Fig. 4 . Surface under the cumulative ranking curve for the incidence of post-operative nausea and vomiting for the 3 anesthetics.
after administration of des urane and the conventional maintenance anesthetics sevo urane and propofol in patients undergoing laparoscopic surgery. The results demonstrated that there were no signi cant differences in the incidence of PONV when comparing des urane and sevo urane or des urane and propofol. These results are consistent with a previous meta-analysis, which also demonstrated no signi cant difference between des urane and sevo urane in in uencing the incidence of PONV in patients undergoing surgery under general anesthesia 16 . In contrast, this study showed that the odds of PONV occurring after propofol administration were signi cantly lower than after sevo urane administration, which was expected. Of the 3 anesthetics, propofol exhibited the highest SUCRA score and the highest probability of being the best treatment. Of the remaining 2 anesthetics, des urane had a higher SUCRA score and a higher probability of being the best treatment than sevoflurane. These results might be biologically plausible given that the pharmacokinetic properties of des urane allow fast anesthesia induction and recovery, high molecular stability, and minimal metabolic degradation. Des urane also has the lowest organic toxicity of all halogenated anesthetics and is well-tolerated by the human body 4 5 . Our results suggest that des urane is a safe anesthetic in terms of the incidence of PONV, and could be an alternative to guideline-recommended conventional anesthetics in patients undergoing laparoscopic surgery under general anesthesia. The present study is the first network meta-analysis to compare the incidence of PONV between des urane and the conventional maintenance anesthetics sevo urane and propofol with a focus on patients undergoing laparoscopy under general anesthesia. Although previous studies directly compared the effects of these 3 anesthetics in all combinations on the incidence of PONV, our study statistically integrates direct and indirect comparisons and also allows simultaneous comparison of multiple treatments [17] [18] [19] .
However, the present study has several limitations. First, we considered published studies only. Therefore it is possible that the present results might suffer from publication bias. Second, metaanalysis is a form of retrospective research ; therefore, it is subject to the same methodological limitations as all retrospective studies, including the possibility of outcome selection bias. In particular, we considered that further analysis was required because the results published by Erk and colleagues 7 might have been obtained by using a statistical method with insuf cient accuracy, even though this study had a high Jadad score. Third, the sample size in the present study was small : only 4 RCTs were analyzed. Meta-analysis of 4 or fewer studies is not uncommon, as seen in studies on orphan disease. Nevertheless, issues addressed by these meta-analyses might be considered unresolved in the presence of heterogeneity. Fortunately, the present data did not exhibit any heterogeneity. Finally, there is still no consensus whether the results of networkmeta-analysis or pairwise meta-analysis provide more reliable and useful information about clinical practice. Further analysis including direct comparisons are essential to understanding the clinical ef cacy and safety of these agents. In summary, the results of this network meta-analysis suggest that desflurane is a safe anesthetic in terms of the incidence of PONV. Des urane could be used as an alternative to guideline-recommended conventional anesthetics in patients undergoing laparoscopic surgery under general anesthesia. However, considering the limitations of this meta-analysis, further research is required to con rm the safety and ef cacy of anesthesia with des urane in patients undergoing laparoscopic surgery.
